1. 565PDose finding and safety study of reovirus (Reo) with irinotecan/ fluorouracil/ leucovorin/ bevacizumab (FOLFIRI/B) in patients with KRAS mutant metastatic colorectal cancer (mCRC): Final results. (23rd October 2018) Authors: Goel, S; Ocean, A; Parakrama, R; Ghalib, M H; Chaudhary, I; Shah, U; Coffey, M; Kaledzi, E; Maitra, R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P-059SM-88 therapy in high-risk poor prognosis pancreatic cancer (PDAC). (2nd July 2019) Authors: Noel, M; Wang-Gillam, A; Ocean, A; Chawla, S; Chung, V; DelPriore, G; Picozzi, V Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P-155Open-label, multicenter, single-arm study of FABLOx (metronomic 5-fluorouracil plus nab-paclitaxel, bevacizumab, leucovorin, and oxaliplatin) in patients with metastatic pancreatic cancer: Phase I results. (20th June 2018) Authors: Sahai, V; Saif, W; Kalyan, A; Philip, P; Rocha-Lima, C; Ocean, A; Ondovik, M; Simeone, D; Karnoub, M; Louis, C; Picozzi, V Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P-232RENCA macrobead therapy (RMB): A biological-systems approach to metastatic colorectal cancer [U.S. FDA BB-IND 10091]. (2nd July 2019) Authors: Nazarian, A; Sureshbabu, S; Berman, N; Wolf, D; Gazda, L; Fahey, T; Ocean, A; Smith, B Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗